Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group

Affiliations

• ¹ From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. [email protected].
• ² F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital. [email protected].
• ³ From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
• ⁴ F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.